Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 3
2008 2
2009 4
2010 3
2012 3
2013 5
2014 4
2015 5
2016 2
2017 1
2018 2
2019 1
2022 1
2023 2
2024 1
2025 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

33 results

Results by year

Filters applied: . Clear all
Page 1
Beneficial Effects of Pentoxifylline Plus Losartan Dual Therapy in Type 2 Diabetes with Nephropathy.
Rabizadeh S, Dehghani Firouzabadi F, Noshad S, Esteghamati S, Afarideh M, Ghajar A, Ganji M, Saadat M, Heidari B, Najafi MT, Nakhjavani M, Esteghamati A. Rabizadeh S, et al. Am J Med Sci. 2018 May;355(5):442-448. doi: 10.1016/j.amjms.2017.12.015. Epub 2018 Feb 1. Am J Med Sci. 2018. PMID: 29753374 Clinical Trial.
BACKGROUND: This study was designed to comparatively assess the effects of add-on pentoxifylline to losartan versus increasing the dose of losartan on serum N-terminal pro-brain natriuretic peptide (NT-proBNP), serum highly sensitive C-reactive protein (hsCRP) and the urin …
BACKGROUND: This study was designed to comparatively assess the effects of add-on pentoxifylline to losartan versus increasing the dose of l …
Lipid profile, ox-LDL, and LCAT activity in patients with endometrial carcinoma and type 2 diabetes: The effect of concurrent disease based on a case-control study.
Qahremani R, Rabizadeh S, Mirmiranpoor H, Yadegar A, Mohammadi F, Sahebi L, Heidari F, Esteghamati A, Nakhjavani M. Qahremani R, et al. Health Sci Rep. 2023 Sep 1;6(9):e1537. doi: 10.1002/hsr2.1537. eCollection 2023 Sep. Health Sci Rep. 2023. PMID: 37662543 Free PMC article.
The participants were divided into four groups, including EC with type 2 diabetes (n = 19), EC without type 2 diabetes (n = 17), type 2 diabetes (n = 31), and healthy controls (n = 26). ...
The participants were divided into four groups, including EC with type 2 diabetes (n = 19), EC without type 2 diabetes (n = 17 …
Vitamin C supplementation lowers advanced glycation end products (AGEs) and malondialdehyde (MDA) in patients with type 2 diabetes: A randomized, double-blind, placebo-controlled clinical trial.
Rabizadeh S, Heidari F, Karimi R, Rajab A, Rahimi-Dehgolan S, Yadegar A, Mohammadi F, Mirmiranpour H, Esteghamati A, Nakhjavani M. Rabizadeh S, et al. Food Sci Nutr. 2023 Jun 30;11(10):5967-5977. doi: 10.1002/fsn3.3530. eCollection 2023 Oct. Food Sci Nutr. 2023. PMID: 37823170 Free PMC article.
Of the 70 subjects assigned to the trial, 57 were included in the statistical analysis (vitamin C: n = 32, placebo: n = 25). Inflammatory and oxidative markers, including advanced glycation end products (AGEs), malondialdehyde (MDA), advanced oxidation protein produ …
Of the 70 subjects assigned to the trial, 57 were included in the statistical analysis (vitamin C: n = 32, placebo: n = 25). I …
Circulating levels of fibroblast growth factor 21 in early-stage diabetic kidney disease.
Esteghamati A, Khandan A, Momeni A, Behdadnia A, Ghajar A, Nikdad MS, Noshad S, Nakhjavani M, Afarideh M. Esteghamati A, et al. Ir J Med Sci. 2017 Aug;186(3):785-794. doi: 10.1007/s11845-017-1554-7. Epub 2017 Feb 8. Ir J Med Sci. 2017. PMID: 28181108
METHODS: Cross-sectionally, 130 consecutive individuals comprising patients with T2D with (n = 44) or without (n = 44) microalbuminuria and their healthy controls (n = 42) were recruited for analysis. ...
METHODS: Cross-sectionally, 130 consecutive individuals comprising patients with T2D with (n = 44) or without (n = 44) microal …
Plasma levels of miR-21, miR-150, miR-423 in patients with lupus nephritis.
Nakhjavani M, Etemadi J, Pourlak T, Mirhosaini Z, Zununi Vahed S, Abediazar S. Nakhjavani M, et al. Iran J Kidney Dis. 2019 May;13(3):198-206. Iran J Kidney Dis. 2019. PMID: 31209193 Free article.
METHODS: The aim of this study was to investigate the diagnostic values of circulating miR-21, miR-148a, miR-150, and miR-423 involved in autoimmunity and kidney fibrosis in plasma samples of LN cases (N = 26) and healthy controls (N = 26) using quantitative- PCR (q …
METHODS: The aim of this study was to investigate the diagnostic values of circulating miR-21, miR-148a, miR-150, and miR-423 involved in au …
Reduction in asymmetric dimethylarginine plasma levels by coenzyme Q10 supplementation in patients with type 2 diabetes mellitus.
Hosseinzadeh-Attar M, Kolahdouz Mohammadi R, Eshraghian M, Nakhjavani M, Khorrami E, Ebadi M, Esteghamati A. Hosseinzadeh-Attar M, et al. Minerva Endocrinol. 2015 Dec;40(4):259-66. Epub 2015 Jul 3. Minerva Endocrinol. 2015. PMID: 26140473 Clinical Trial.
METHODS: Sixty-four type 2 diabetic patients were randomly assigned to two groups; either receiving 200mg/d oral dose of CoQ10 (N.=31) or receiving placebo (N.=33) for 12 weeks. Clinical and biochemical assessments were performed before and after the trial for evalu …
METHODS: Sixty-four type 2 diabetic patients were randomly assigned to two groups; either receiving 200mg/d oral dose of CoQ10 (N.=31 …
Comparative effects of metformin and pioglitazone on YKL-40 in type 2 diabetes: a randomized clinical trial.
Esteghamati A, Rezvani S, Khajeh E, Ebadi M, Nakhjavani M, Noshad S. Esteghamati A, et al. J Endocrinol Invest. 2014 Dec;37(12):1211-8. doi: 10.1007/s40618-014-0154-x. Epub 2014 Aug 20. J Endocrinol Invest. 2014. PMID: 25138574 Clinical Trial.
NCT01521624), 84 newly diagnosed, medication-naive type 2 diabetes patients were assigned to metformin 1,000 mg daily (n = 42) or pioglitazone 30 mg daily (n = 42). Serum concentrations of YKL-40, along with highly sensitive C-reactive protein, indices of glycemic c …
NCT01521624), 84 newly diagnosed, medication-naive type 2 diabetes patients were assigned to metformin 1,000 mg daily (n = 42) or pio …
The insertion/deletion polymorphism of the angiotensin-converting enzyme gene is associated with progression, but not development, of albuminuria in Iranian patients with type 2 diabetes.
Nikzamir A, Esteghamati A, Feghhi M, Nakhjavani M, Rashidi A, Reza JZ. Nikzamir A, et al. J Renin Angiotensin Aldosterone Syst. 2009 Jun;10(2):109-14. doi: 10.1177/1470320309104872. J Renin Angiotensin Aldosterone Syst. 2009. PMID: 19502259 Free article.
METHODS: Patients (322; 162 males) with type 2 diabetes were categorised in this cross-sectional study into the following groups: normoalbuminuria (n=145), microalbuminuria (n=129) and macroalbuminuria (n=48).ACE gen I/D polymorphism genotypes were determined …
METHODS: Patients (322; 162 males) with type 2 diabetes were categorised in this cross-sectional study into the following groups: normoalbum …
Effect of spermine on lipid profile and HDL functionality in the streptozotocin-induced diabetic rat model.
Jafarnejad A, Bathaie SZ, Nakhjavani M, Hassan MZ. Jafarnejad A, et al. Life Sci. 2008 Jan 30;82(5-6):301-7. doi: 10.1016/j.lfs.2007.11.015. Epub 2007 Dec 5. Life Sci. 2008. PMID: 18164731
Male Wistar rats were divided into 4 groups (control, n=7; diabetic, n=9). Two groups (named 2 and 3) were injected intraperitoneally with streptozotocin. ...
Male Wistar rats were divided into 4 groups (control, n=7; diabetic, n=9). Two groups (named 2 and 3) were injected intraperit …
33 results